GASTON-DREYFUS REMI purchased 11.0% of their position (180.56K shares) of BIONIK LABORATORIES CORP. on the open market
Open‑market purchase worth $108.3K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/21/2023ACC: 0001104659-23-073229
Director10% Owner
Since Jul 2018
+180.56K
Net shares
Net buyer
$108.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
180.56K acquired
Non-Derivative Transactions1
Common Stock, par value $0.001 per share
Indirect
Shares
+180.56K
Price / share
$0.60
Trade value
$108.33K
% of position
11.0%
6/9/2023
1.63M→1.81M
Total
Net shares
+180.56K
Net value
$108.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share Indirect | 6/9/2023 | P · Purchase | +180.56K | $0.60 | $108.33K | 11.0% | 1.63M | 1.81M |
| Total | +180.56K | $108.33K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock, par value $0.001 per share
DirectShares owned61.26K
Total
61.26K direct61.26K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.001 per share | 61.26K | Direct |
| Total | 61.26K | 61.26K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported